DELFI's AI and whole-genome sequencing platform detects cancer-associated cfDNA fragmentation patterns in the blood.
Funding
Growth Stage
Current Stage
$225M
Recent Funding
$331.57M
Total Funding
Recent News
Delfi Diagnostics Announces $225 Million in Series B
The SaaS News